Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
F1000Research|March 24, 2018
Renal cell carcinoma: a review of biology and pathophysiologyShahzaib Nabi, Elizabeth R Kessler, Brandon Bernard, et al.
Cancer|November 27, 2019
Impact of age at diagnosis of de novo metastatic prostate cancer on survivalBrandon Bernard, Colin Burnett, Christopher J Sweeney, et al.
The Journal of Ambulatory Care Management|February 17, 2025
Moving Beyond Viral Suppression: Strengthening the Community HIV Workforce to Improve Empowerment and Reduce Stigma in the Memphis Transitional Grant AreaSerena Rajabiun, Noelle Wiggins, Abigail Smack, et al.
Clinical Genitourinary Cancer|August 31, 2017
Smoking and Disease Outcomes in Patients With Malignant Germ Cell TumorsElizabeth O'Donnell, Sarah C Markt, Rowan Miller, et al.
European Urology Focus|July 30, 2017
Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended ChemotherapyRowan E Miller, Sarah C Markt, Elizabeth O'Donnell, et al.
Gynecologic Oncology|October 19, 2013
Uterine adenosarcomas: a dual-institution update on staging, prognosis and survivalBrandon Bernard, Blaise A Clarke, Janet I Malowany, et al.
Clinical Colorectal Cancer|September 18, 2016
A Comparison of Survival by Site of Metastatic Resection in Metastatic Colorectal CancerRichard Lee-Ying, Brandon Bernard, Gillian Gresham, et al.
Cancer|January 6, 2017
Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancerBrandon Bernard, Vinayak Muralidhar, Yu-Hui Chen, et al.
Clinical Genitourinary Cancer|October 18, 2020
Prostate Cancer Central Nervous System Metastasis in a Contemporary CohortPeter J Boxley, Derek E Smith, Dexiang Gao, et al.
The Prostate|May 1, 2018
Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC)Edoardo Francini, Kathryn P Gray, Wanling Xie, et al.
Pageof 3